|
|
| Type |
Symposium |
| Area |
The Cutting Edge of Drug Discovery Chemistry |
| Room No. |
Room 304 |
| Time |
THU 15:40-16:10 |
| Code |
MEDI-1 |
| Subject |
AI Drug Discovery & Precision Medicine |
| Authors |
Tyson Kim
Syntekabio, Inc., Korea |
| Abstract |
Big pharmas are investing astronomical money and long time with high risk to develop a blockbuster. Recently, a variety of new attempts have been made to increase the efficiency of new drug development using AI technology. Syntekabio also seeking to improve the value of new drugs by developing genome-based big data with AI in the shift of precision medicine paradigm. |
| E-mail |
tysonkim@syntekabio.com |
|
123rd General Meeting of the KCS